Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03241368 · ClinicalTrials.gov registry record · NA

Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.

A NA study of Crohn Disease, sponsored by Medtronic - MITG.

Completed
Registry status
NA
Development phase
187
Enrollment target
20
Study locations

NCT03241368 is a NA study of Crohn Disease that has completed, run by Medtronic - MITG. The registered enrollment target is 187 participants, roughly in line with the 203-participant average among 71 other Crohn Disease trials with a reported enrollment target. The trial reports 20 study locations across 18 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03241368, a NA study of Crohn Disease, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
NA
Development phase
187 participants
Enrollment target
20
Study locations

Study Summary

This study will evaluate the efficacy of capsule endoscopy (CE) versus ileocolonoscopy (IC) plus MRE for detection of active Crohn's disease (CD) in the small bowel in subjects with known CD and mucosal disease. The primary objective of the study is to assess the accuracy of CE versus IC plus MRE for detecting active CD, by visualizing the small bowel and colon in subjects with known CD and mucosal disease. There will be assessment of mucosal disease activity at baseline. Patient satisfaction questionnaire will be completed at baseline.

Conditions Studied

Crohn Disease

Interventions

  • DEVICE Capsule Endoscopy

Study Locations (20)

Indiana

  • Indiana University - Indianapolis
  • Indianapolis Gastroenterology Research Foundation - Indianapolis

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland
  • The Ohio State University Medical Center - Columbus

Alabama

  • University of South Alabama - Mobile

Arizona

  • Mayo Clinic (Scottsdale, AZ) - Scottsdale

Florida

  • Encore Borland Groover Clinical Research - Jacksonville

Georgia

  • Children's Center for Digestive Healthcare - Atlanta

Illinois

  • Loyola University - Chicago - Maywood

Kansas

  • University of Kansas - Kansas City

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2017-12-21
Est. Completion 2019-06-20
Phase NA

Sponsor

Medtronic - MITG

119 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03241368

The ClinicalTrials.gov registry entry for NCT03241368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 203-participant average among 71 other Crohn Disease trials with a reported enrollment target. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 1 intervention - of which Capsule Endoscopy is the first listed.

NCT03241368 reports 20 study locations spanning 18 distinct geographic areas - top geographies include Indiana, Ohio, Alabama.

Frequently Asked Questions

What is clinical trial NCT03241368 about?

NCT03241368 is a clinical study titled "Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.". This study will evaluate the efficacy of capsule endoscopy (CE) versus ileocolonoscopy (IC) plus MRE for detection of active Crohn's disease (CD) in the small bowel in subjects with known CD and mucosal disease. The primary objective of the study is to assess the accuracy of CE versus IC plus MRE f...

What is the current status of trial NCT03241368?

This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2017-12-21. Estimated completion is 2019-06-20.

What conditions does trial NCT03241368 study?

This clinical trial studies the following conditions: Crohn Disease.

What interventions are being tested in trial NCT03241368?

The interventions under investigation include: Capsule Endoscopy (DEVICE).

Who is sponsoring clinical trial NCT03241368?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03241368 being conducted?

This trial has 20 study locations across Alabama, Arizona, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Crohn Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Crohn Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.